Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...

Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg report that revealed ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...

After Bloomberg reported, citing people familiar with the probe, that the Federal Trade Commission has been investigating ...

For more than a year, the Federal Trade Commission has been investigating Hims & Hers Health Inc.’s business practices, including whether it has made it too hard for customers to cancel subscriptions, ...

Stock index futures rose on Friday, with Dow futures leading the charge, as UnitedHealth got a boost after Berkshire Hathaway ...

Investing.com -- Hims & Hers Health (NYSE:HIMS) stock dropped 2.6% on Friday following reports that the Federal Trade Commission has been investigating the telehealth company's business practices for ...

The U.S. Federal Trade Commission is probing complaints about telehealth platform Hims & Hers regarding its advertising and ...

The US health sector is bustling with activity. Key developments include an FTC investigation into Hims & Hers' practices, ...

Allen Lutz has given his Buy rating due to a combination of factors including the strong brand equity of Hims & Hers Health and the strategic appointment of a new board member with significant ...

Berkshire Hathaway invests in UnitedHealth; FTC investigates Hims & Hers for advertising practices; U.S. health department ...